Keele Research Repository
Explore the Repository
Article
Alabas, O, Mason, KJ
ORCID: https://orcid.org/0000-0002-5419-0669, Yiu, Z, Warren, R, Lunt, M, Smith, C and Griffiths, C
(2022)
Real-world effectiveness and persistence of methotrexate versus adalimumab: A comparative study from the British association of dermatologists biologics and immunomodulators register (BADBIR).
Pharmacoepidemiology and Drug Safety, 31 (S2).
490 - 490.
Warren, RB, Marsden, A, Tomenson, B, Mason, KJ
ORCID: https://orcid.org/0000-0002-5419-0669, Soliman, MM, Burden, AD, Reynolds, NJ, Stocken, D, Emsley, R, Griffiths, CEM, Smith, C, Consortium, PSORT and Study Group, BADBIR
(2018)
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.
British Journal of Dermatology, 180 (5).
1069 - 1076.
Kishore, A, Vail, A, Bray, B, Chamorro, A, Di Napoli, M, Kalra, L, Langhorne, P, Montaner, J, Roffe, C
ORCID: https://orcid.org/0000-0002-5259-6649, Rudd, A, Tyrrell, A, Van de Beek, D, Woodhead, M, Meisel, A and Smith, C
(2016)
Clinical risk scores for predicting stroke-associated pneumonia: A systematic review.
European Stroke Journal, 1 (2).
76 - 84.
Cohen, DL, Roffe, C, Beavan, J, Blackett, B, Fairfield, CA, Hamdy, S, Havard, D, McFarlane, M, McLaughlin, C, Randall, M, Robson, K, Scutt, P, Smith, C, Smithard, D, Sprigg, N, Warusevitane, A, Watkins, C, Woodhouse, L and Bath, PM (2016) Post-stroke dysphagia: A review and design considerations for future trials. International Journal of Stroke, 11 (4). 399 - 411.
Gándara, E, Warusevitane, A, Karunatilake, D, Sim, J
ORCID: https://orcid.org/0000-0002-1816-1676, Smith, C and Roffe, C
(2016)
Early Diagnosis of Pneumonia in Severe Stroke: Clinical Features and the Diagnostic Role of C-Reactive Protein.
PLoS One, 11 (3).
0150269-?.
Conference or Workshop Item
Roffe, C
ORCID: https://orcid.org/0000-0002-5259-6649, Bath, P, Warusevitane, A, Smith, C, Dixit, A, Sprigg, N, Helliwell, B, Phillips, N, Sim, J, Jowett, S and Ogollah, R
(2021)
THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2) TRIAL: A SINGLE-BLIND RCT OF METOCLOPRAMIDE FOR THE PREVENTION OF PNEUMONIA IN PATIENTS WITH DYSPHAGIA AFTER STROKE.
In: UK Stroke Forum 2021, 30 Nov - 02 Dec 2021, Virtual.

Up a level
